The 340B drug plan language that was recently added into SB 494 risks increasing costs for the very patients it purports to help.

It is time to regulate and reform the 340B drug-pricing program on the federal level.

Prescription drug affordability boards are a hot idea for states to enact right now, but there is no actual track record yet of success.